We continue to monitor guidance from the Centers for Medicare & Medicaid Service (CMS) regarding Medicare Secondary Payer (MSP) compliance as related to workers’ compensation, liability, and no-fault insurance claims. As we often discuss here on our blog, CMS continues to place emphasis on satisfying MSP obligations. You may recall that in December 2018, CMS […] Continue
Patients with chronic pain often present a challenging treatment scenario for health care practitioners. This has historically been the case, and the opioid crisis has served to create additional challenges by discouraging the use of opioids which have traditionally been the mainstays of pain therapy. Because of the opioid epidemic, treatment guidelines have emerged which […] Continue
Today, the Centers for Medicare & Medicaid Services (CMS) released a revised Workers’ Compensation Medicare Set-Aside (WCMSA) Reference Guide. The updated guide is version 3.1, dated May 11, 2020, and can be found here. As with other versions of the guide, a summary of updates to the guide are found in Section 1.1. The only update […] Continue
MEDVAL is pleased to announce its new Post-Settlement Administration Services offered through MEDVAL Rx. These services are available to individuals who have funds in a Medicare-Set-Aside (MSA) account to pay for future prescription expenses. MEDVAL Rx historically limited these services to MSAs that were professionally administered, but all self-administered MSA accounts, regardless of which vendor […] Continue
Last Friday, while many of us may have been focused on Valentine’s Day activities, the Food and Drug Administration (FDA) was busy granting over-the-counter status to three products which were previously available only by prescription. One of those products was Voltaren (diclofenac) 1% gel, which is manufactured by GSK. When the product makes its OTC […] Continue